These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 35128362)
1. Patients with MPNs and retinal drusen show signs of complement system dysregulation and a high degree of chronic low-grade inflammation. Liisborg C; Skov V; Kjær L; Hasselbalch HC; Sørensen TL EClinicalMedicine; 2022 Jan; 43():101248. PubMed ID: 35128362 [TBL] [Abstract][Full Text] [Related]
2. Age-related macular degeneration and myeloproliferative neoplasms - A common pathway. Liisborg C Acta Ophthalmol; 2022 Oct; 100 Suppl 271(Suppl 271):3-35. PubMed ID: 36200281 [TBL] [Abstract][Full Text] [Related]
3. Lower CXCR3 expression in both patients with neovascular AMD and advanced stages of chronic myeloproliferative blood cancers. Liisborg C; Skov V; Kjær L; Hasselbalch HC; Lykke Sørensen T PLoS One; 2022; 17(6):e0269960. PubMed ID: 35709177 [TBL] [Abstract][Full Text] [Related]
4. Serum levels of IL-4, IL-13 and IL-33 in patients with age-related macular degeneration and myeloproliferative neoplasms. Gotfredsen K; Liisborg C; Skov V; Kjær L; Hasselbalch HC; Sørensen TL Sci Rep; 2023 Mar; 13(1):4077. PubMed ID: 36906669 [TBL] [Abstract][Full Text] [Related]
5. Retinal drusen in patients with chronic myeloproliferative blood cancers are associated with an increased proportion of senescent T cells and signs of an aging immune system. Liisborg C; Skov V; Kjær L; Hasselbalch HC; Sørensen TL Aging (Albany NY); 2021 Dec; 13(24):25763-25777. PubMed ID: 34954692 [TBL] [Abstract][Full Text] [Related]
6. Patients with myeloproliferative neoplasms and high levels of systemic inflammation develop age-related macular degeneration. Liisborg C; Nielsen MK; Hasselbalch HC; Sørensen TL EClinicalMedicine; 2020 Sep; 26():100526. PubMed ID: 33089124 [TBL] [Abstract][Full Text] [Related]
7. Age-Related Macular Degeneration in Patients With Chronic Myeloproliferative Neoplasms. Bak M; Sørensen TL; Flachs EM; Zwisler AD; Juel K; Frederiksen H; Hasselbalch HC JAMA Ophthalmol; 2017 Aug; 135(8):835-843. PubMed ID: 28655032 [TBL] [Abstract][Full Text] [Related]
8. Classical Philadelphia-negative myeloproliferative neoplasms (MPNs): A continuum of different disease entities. Coltro G; Loscocco GG; Vannucchi AM Int Rev Cell Mol Biol; 2021; 365():1-69. PubMed ID: 34756241 [TBL] [Abstract][Full Text] [Related]
9. Peripheral retinal drusen and reticular pigment: association with CFHY402H and CFHrs1410996 genotypes in family and twin studies. Seddon JM; Reynolds R; Rosner B Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):586-91. PubMed ID: 18936151 [TBL] [Abstract][Full Text] [Related]
10. Association of Systemic Inflammatory Factors with Progression to Advanced Age-related Macular Degeneration. Wagner BD; Patnaik JL; Palestine AG; Frazer-Abel AA; Baldermann R; Holers VM; Mathias MT; Mandava N; Lynch AM Ophthalmic Epidemiol; 2022 Apr; 29(2):139-148. PubMed ID: 33827374 [TBL] [Abstract][Full Text] [Related]
11. Drusen and pigment abnormality predict the development of neovascular age-related macular degeneration in Japanese patients. Notomi S; Shiose S; Ishikawa K; Fukuda Y; Kano K; Mori K; Wada I; Kaizu Y; Matsumoto H; Akiyama M; Sonoda KH PLoS One; 2021; 16(7):e0255213. PubMed ID: 34314466 [TBL] [Abstract][Full Text] [Related]
12. Molecular composition of drusen and possible involvement of anti-retinal autoimmunity in two different forms of macular degeneration in cynomolgus monkey (Macaca fascicularis). Umeda S; Suzuki MT; Okamoto H; Ono F; Mizota A; Terao K; Yoshikawa Y; Tanaka Y; Iwata T FASEB J; 2005 Oct; 19(12):1683-5. PubMed ID: 16099945 [TBL] [Abstract][Full Text] [Related]
13. Clinical Manifestations and Risk Factors for Complications of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms. Duangnapasatit B; Rattarittamrong E; Rattanathammethee T; Hantrakool S; Chai-Adisaksopha C; Tantiworawit A; Norasetthada L Asian Pac J Cancer Prev; 2015; 16(12):5013-8. PubMed ID: 26163633 [TBL] [Abstract][Full Text] [Related]
14. [Age-related Macular Degeneration in the Japanese]. Yoshimura N Nippon Ganka Gakkai Zasshi; 2016 Mar; 120(3):163-88; discussion 189. PubMed ID: 27164756 [TBL] [Abstract][Full Text] [Related]
15. Inflammation, complement factor h, and age-related macular degeneration: the Multi-ethnic Study of Atherosclerosis. Klein R; Knudtson MD; Klein BE; Wong TY; Cotch MF; Liu K; Cheng CY; Burke GL; Saad MF; Jacobs DR; Sharrett AR Ophthalmology; 2008 Oct; 115(10):1742-9. PubMed ID: 18538409 [TBL] [Abstract][Full Text] [Related]
16. High Risk Janus Kinase 2 V617F Allele Burden in a Seven-Year Cohort of Patients with Myeloproliferative Neoplasms. Chatambudza M; Skhosana L; Ketseoglou I; Wiggill T Clin Lab; 2021 Nov; 67(11):. PubMed ID: 34758219 [TBL] [Abstract][Full Text] [Related]
18. Association Between Perifoveal Drusen Burden Determined by OCT and Genetic Risk in Early and Intermediate Age-Related Macular Degeneration. Seddon JM; Dossett JP; Widjajahakim R; Rosner B Invest Ophthalmol Vis Sci; 2019 Oct; 60(13):4469-4478. PubMed ID: 31658355 [TBL] [Abstract][Full Text] [Related]
19. Drusen Volume as a Predictor of Disease Progression in Patients With Late Age-Related Macular Degeneration in the Fellow Eye. Abdelfattah NS; Zhang H; Boyer DS; Rosenfeld PJ; Feuer WJ; Gregori G; Sadda SR Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1839-46. PubMed ID: 27082298 [TBL] [Abstract][Full Text] [Related]
20. Incidence and progression of reticular drusen in age-related macular degeneration: findings from an older Australian cohort. Joachim N; Mitchell P; Rochtchina E; Tan AG; Wang JJ Ophthalmology; 2014 Apr; 121(4):917-25. PubMed ID: 24332537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]